期刊名称:YONSEI MEDICAL JOURNAL
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About the YMJ |
|
Yonsei Medical Journal (YMJ) was first published in 1960. It was initially published once a year but became a biannual journal in 1968, a quarterly journal in 1986, and then a bimonthly journal in 1995. YMJ is published bimonthly and issuing dates are the first days of January, March, May, July, September, and November. Abbreviated title is "Yonsei Med J".
Since YMJ became the first Korean journal indexed in Index Medicus in 1962, YMJ has been indexed/tracked/covered by MEDLINE, PubMed, PubMed Central, Science Citation Index (SCI), BIOSIS Previews, SCOPUS, Embase, Chemical Abstracts Service (CAS), KoreaMed, Synapse, KoMCI, CrossRef and Google Scholar. Full text PDF files are available at www.eYMJ.org.
In-Hong Choi, M.D., Ph.D., Editor in Chief Yonsei Medical Journal Yonsei University College of Medicine 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: 82-2-2228-2034, Fax: 82-2-393-4945, E-Mail: ymj@yuhs.ac
Aims and Scope |
|
The goal of the Yonsei Medical Journal (YMJ) is to publish high quality manuscripts dedicated to clinical or basic research. Any authors affiliated with an accredited biomedical institution may submit manuscripts of original articles, review articles, case reports, brief communications, and letters to the Editor. |
|
Instructions to Authors
Information for Contributors |
EDITORIAL POLICY:
The goal of the Yonsei Medical Journal (YMJ) is to publish high quality manuscripts dedicated to clinical or basic research. Any authors affiliated with an accredited biomedical institution may submit manuscripts of original articles, review articles, case reports, brief communications, and letters to the Editor. Manuscripts are received with the understanding that they are not under simultaneous consideration by any other publications, and that the authors realize that the identities of the reviewers are kept confidential. The Editors reserve the right to make corrections, both literary and technical, to the papers. It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and follows all guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. YMJ is published bimonthly and issuing dates are the first days of January, March, May, July, September, and November. The copyright of published manuscripts is held by the YMJ. The agreement of copyright transfer from all the authors should be sent with the original manuscript submission. A copyright transfer form is available at the journal homepage.
CONFLICTS OF INTEREST:
Any potential conflicts of interest must be disclosed in this section. If there are no potential financial conflicts of interest, the following statement should be added: "The authors have no financial conflicts of interest."
ETHICS:
Any study involving human subject or human data must be approved by the Institutional Review Board (IRB) of the author's affiliated organization. Please refer to the principles embodied in the Declaration of Helsinki ( http://www.wma.net/e/policy/b3.htm). Animal studies should be performed in compliance with relevant guidelines and approved by the IRB. A statement regarding IRB approval should be included in the Materials and Methods section.
MANUSCRIPT SUBMISSION:
Authors should submit manuscripts via the online submission system: http://journal.eymj.org. Acceptance of manuscripts is based on many factors, including the importance, originality, and priority of the research. The Editor-in-Chief and an Associate Editor generally review manuscripts. Then the selected manuscripts are reviewed by at least two external peer reviewers, and when required, a biostatistician. Upon completion of the review, authors will receive notification of the Editor's decision by e-mail with comments offered by the reviewers. The author(s) can recommend up to 5 candidates to review the manuscript. Revised manuscripts must be submitted within 3 months of the date on the decision letter in order to maintain their original manuscript number.
PREPARATION OF MANUSCRIPT:
Authors should refer to "Uniform Requirements for Manuscripts Submitted to Biomedical Journals"( http://www.icmje.org). On the cover letter, authors should make a statement about the originality of their work and disclose previous presentations, reports, or publications that contain any material that appears in the manuscript. If there is a similar or supplemental publication, the authors should provide a copy for the Editors' review. Manuscripts should be written in double space throughout.
REVIEW ARTICLE:
Review articles are usually solicited by the Editor-in-Chief. However, unsolicited Reviews will be also considered. Authors should contact the Editor-in-Chief in advance to determine the appropriateness of their Review Articles for publication. Unsolicited Reviews will undergo peer review. An Abstract is required whereas Materials and Methods section and a Results section are not required. The length of Review Articles is limited to 5,000-8,000 words with a maximum of 100 references. Also, there should be no more than 3 authors.
ORIGINAL ARTICLE:
Manuscripts should begin with the title page followed by an abstract; a list of key words; an introduction; materials and methods; results; a discussion; tables and/or illustrations; and references. Title Page: The tile page should contain the following information: (1) title (less then 100 characters); (2) author list (first name, middle name, and last name); (3) name of the institutions at which the work was performed; (4) acknowledgement of research support; (5) name, address, telephone, fax number, and e-mail address of the corresponding author; (6) running title (less than 50 characters, including spaces); (7) a list of where and when the study has been presented in part elsewhere.
Abstract: Abstract must be organized and formatted according to the following headings: (1) Purpose; (2) Materials and Methods; (3) Results; and (4) Conclusion. A trade name may not be used in the title or abstract. The Abstract length is typically 250 words.
Key Words: List 3-6 key words from the list provided in Index Medicus under "Medical Subject Heading (MeSH)."
Text: The text of manuscripts must have the following sections: (1) Introduction; (2) Materials and Methods; (3) Results; and (4) Discussion. The body of the manuscript should be written as concisely as possible. All pages of the manuscript should be numbered. (1) Introduction: This should provide a context or background for the study and states the specific purpose or research objective of or hypothesis tested by the study. This may include mention of papers most closely related to the article, and of the problem. (2) Materials and Methods: Explanation of the experimental methods should be concise but sufficient to allow other workers to reproduce the results. This provides the technical information, apparatus (the manufacturer's name and brief address) and procedures. Give references and brief descriptions for the methods that have been published. Describe statistical methods with enough detail to enable a reader with access to the original data to verify the reported results. Define statistical terms, abbreviations, and most symbols. (3) Results: This should include a concise textual description of the data presented in tables and figures. (4) Discussion: This section includes the new and important aspects of the study and the conclusions. The data should be interpreted concisely. Speculation is permitted, but it must be supported by the data presented by the authors.
References: References should be numbered consecutively in the order in which they are first mentioned in the text, with numbers as unparenthesized superscripts after any closing punctuation. They should be listed on a separate document under the heading "REFERENCES," and double-spaced. Reference format should conform to that set forth in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals. 5th ed." (JAMA 1997;277:927-34). Titles of journals should be abbreviated according to the Index Medicus style. When referencing from an abstract, editorial, or published letter, it must be identified as such in parentheses at the end of the reference. When a reference is a personal communication, it should be included in parentheses in the body of the text, and not cited in the reference list.
Reference Style:
Journal articles: List all authors when six or less; when seven or more, list the first six and add et al. Vega KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann Intern Med 1996;124:980-3. Book: Ringsven MK, Bond D. Gerontology and leader-ship skills for nurse. 2nd ed. Albany (NY): Delmar Publishers; 1996. Book chapter: Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p.465-78. Tables: Tables should fit within a single page. The Table's legend may include any pertinent notes and must include definitions of all abbreviations and acronyms that have been used in the Table. For footnotes, the following symbols should be used in this sequence: *, †, ‡, §,∥, ¶, **, ††, ‡‡, etc. Authors are obligated to indicate the significance of their observations by appropriate statistical analysis.
Illustrations: Figures must be cited consecutively using Arabic numerals. The recommended fonts within the figures are Helvetica or Arial. Figures which are drawn or photographed professionally should be sent as JPG (JPEG) file. Authors should review the images of such files on a computer screen to be sure they meet their own quality standard. The complete expense of reproducing color photographs will be charged to the author.
Legends for Tables and Illustrations: Typed legends that use double-spacing should start on a separate page with Arabic numerals corresponding to the Tables or Illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the Tables or Illustrations, they should be individually identified and explained clearly in the legend.
Abbreviations: Authors should limit the use of abbreviations to an absolute minimum. Abbreviations are not to be used in titles. Abstracts may contain abbreviations for terms mentioned many times in the abstract section, but each term must be identified the first time it is mentioned.
Unit of Measurement: Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperature should be in degrees Celsius. Authors must consult the information for authors for the particular journal and should report laboratory information in both the local and International System of Units (SI).
BRIEF COMMUNICATION, CASE REPORT, TECHNICAL REPORT, LETTER TO THE EDITOR
Brief communications should not exceed 2,000 words (excluding the Abstract, References, and Figure/Table legends). No subdivisions such as the Introduction, Materials and Methods, Results, and Discussion are required. Case reports should consist of an Abstract, Key words, Introduction, Case Report, Discussion and References (no more than 20). Case reports should have fewer than nine authors, no more than three tables or figures, and should not exceed 1,000 words (excluding the Abstract, References, and Figure/Table legends). Technical reports should not exceed 2,000 words (excluding the Abstract, References, and Figure/Table legends) with up to 20 references. The abstract should be concisely written (fewer than 250 words). It is not necessary to have a fully structured abstract for brief communications, case reports, and technical reports. Letters to the editor should have fewer than five authors, include no more than one table or figure, and should not exceed 750 words. PERMISSION: If any portion of a manuscript has been previously published, the original source must be acknowledged, and the written permission from the copyright holder to reproduce the material must be submitted.
REPRINTS: The reprint order form must be returned along with the corrected galley proofs. Purchased reprints are normally shipped 3 weeks after publication of the journal.
PAGE CHARGES: Page charges are $300 per 6 printed pages or less (original articles, review articles), $250 per 4 printed pages or less (case reports, brief communications, letters), and $50 per additional page. The surcharge for color figures is $150 per color page. Invited review articles are exempt from page charges.
All correspondences, business communications and manuscripts should be mailed to: In-Hong Choi, M.D., Ph.D., Editor-in-Chief
Yonsei Medical Journal
Yonsei University College of Medicine
50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea
Office Tel: 82-2-2228-2034, Fax: 82-2-393-4945
| | |
Instructions to Authors YMJ-InformationForContributors-201404.pdf
Editorial Board
|
Editor in Chief |
|
In-Hong Choi, M.D., Ph.D., Yonsei Univ., Korea |
|
http://orcid.org/0000-0001-9851-0137 |
|
|
|
Associate Editor |
|
Chang-Ok Suh, M.D., Ph.D., Yonsei Univ., Korea |
|
http://orcid.org/0000-0002-3375-7072 |
|
|
|
Executive Editor |
|
Jung-Won Park, M.D., Ph.D., Yonsei Univ., Korea |
|
|
|
Editorial Board |
|
Sharon Adler, M.D., Harbor-UCLA Medical Center, USA |
|
Joong Bae Ahn, M.D., Ph.D., Yonsei Univ., Korea |
|
Shiro Amano, M.D., Ph.D., Univ. of Tokyo, Japan |
|
Seungmin Bang, M.D., Ph.D., Yonsei Univ., Korea |
|
Perry F. Bartlett, BDSc, Ph.D., FAA, Univ. Queensland, Australia |
|
Thomas Bieber, M.D., Ph.D., Univ. of Bonn, Germany |
|
John P. Bilezikian, M.D., Columbia Univ., USA |
|
Malcolm N. Blumenthal, M.D., Univ. Minnesota, USA |
|
Jong-Yil Chai, M.D., Ph.D., Seoul Nat’l Univ., Korea |
|
Jae Hee Cheon, M.D., Ph.D., Yonsei Univ., Korea |
|
Kyunghee C. Cho, M.D., FACR, New Jersey Medical School, USA |
|
Byung Ho Choi, M.D., Ph.D., Univ. California, USA |
|
Hye Jin Choi, M.D., Yonsei Univ., Korea |
|
Hak Choy, M.D., Vanderbilt Univ., USA |
|
Yong-Min Chun, M.D., Ph.D.,Yonsei Univ., Korea |
|
Jin Mo Chung, Ph.D., Univ. Texas, USA |
|
Giovanni Dapri, MD, PhD, FACS, Saint-Pierre Univ. Hospital, Belgium |
|
J. William Futrell, M.D., Univ. Pittsburgh, USA |
|
Won Sik Ham, M.D., Ph.D., Yonsei Univ., Korea |
|
Jung Woo Han, M.D., Yonsei Univ., Korea |
|
Anthony D. Ho, M.D., Univ. Heidelberg, Germany |
|
Waun Ki Hong, M.D., Univ. Texas, USA |
|
Masayuki Imamura, M.D., Ph.D., Kyoto Univ., Japan |
|
Hyeon Joo Jeong, M.D., Ph.D., Yonsei Univ., Korea |
|
Boyoung Joung, M.D., Ph.D., Yonsei Univ., Korea |
|
Chan Y. Jung, Ph.D., State Univ. New York, USA |
|
Kenji Kabashima, M.D., Ph.D., Kyoto Univ., Japan |
|
Eun Seok Kang, M.D., Yonsei Univ., Korea |
|
Do Young Kim, M.D., Ph.D., Yonsei Univ., Korea |
|
Hyoung-Il Kim, M.D., Yonsei Univ., Korea |
|
Jong Sung Kim, M.D., Ph.D., Univ. Ulsan, Korea |
|
Moon Hyun Kim, M.D., Univ. California, USA |
|
Sung Hoon Kim, M.D., Ph.D., Yonsei Univ., Korea |
|
Tae-im Kim, M.D., Ph.D., Yonsei Univ., Korea |
|
Yong Sik Kim, M.D., Ph.D., Seoul Nat’l Univ., Korea |
|
Masaki Kitajima, M.D., International Univ. of Health and Welfare, Japan |
|
Thomas S. Kupper, M.D., Harvard Medical School, USA |
|
Jin Young Kwak, M.D., Yonsei Univ., Korea |
|
Young Lan Kwak, M.D., Ph.D., Yonsei Univ., Korea |
|
Hye-Jeong Lee, M.D., Ph.D., Yonsei Univ., Korea |
|
Jae Woon Lee, Ph.D., Oregon Health & Science Univ., USA |
|
Jeong Rim Lee, M.D., Ph.D., Yonsei Univ., Korea |
|
Phil Hyu Lee, M.D., Ph.D., Yonsei Univ., Korea |
|
Sandra Lee, Sc.D., Harvard School of Public Health, USA |
|
Sang-Hak Lee, M.D., Ph.D., Yonsei Univ., Korea |
|
David J. Lim, M.D., Univ. Southern California, USA |
|
Jong-Baeck Lim, M.D., Ph.D., Yonsei Univ., Korea |
|
Tobias Alecio Mattei, MD, The Ohio State Univ., USA |
|
In Seok Moon, M.D., Ph.D., Yonsei Univ., Korea |
|
Chung Mo Nam, Ph.D., Yonsei Univ., Korea |
|
Jahn M. Nesland, M.D., Ph.D., Univ. of Oslo, Norway |
|
Sang Ho Oh, M.D., Ph.D., Yonsei Univ., Korea |
|
Shin Joong Oh, M.D., Univ. Alabama, USA |
|
Timothy W. Olsen, M.D., Emory Eye Center, USA |
|
Eun Sook Park, M.D., Ph.D., Yonsei Univ., Korea |
|
Young Nyun Park, M.D., Ph.D., Yonsei Univ., Korea |
|
Kenneth J. Pienta, MD, Univ. Michigan, USA |
|
Kishore Sandu, FMH, MD, Univ. Hospital of Lausanne, Switzerland |
|
Dong Yeob Shin, M.D., Yonsei Univ., Korea |
|
Myeong Heon Shin, M.D., Ph.D., Yonsei Univ., Korea |
|
Chang Won Song, Ph.D., Univ. Minnesota, USA |
|
Hiroshi Takami, M.D., Ph.D., Teikyo Univ., Japan |
|
Glenn Talaska, Ph.D., Univ. Cincinnati, USA |
|
William Tasman, M.D., Thomas Jefferson Univ., USA |
|
Hirotsugu Ueshima, M.D., Ph.D., FFPHM, Shiga Univ., Japan |
|
Toshiaki Watanabe, M.D., Teikyo Univ., Japan |
|
John G. Webster, Ph.D., Univ. Wisconsin-Madison, USA |
|
Eung Je Woo, Ph.D., Kyung Hee Univ., Korea |
|
Heun Young Yune, M.D., FACR, Indiana Univ., USA | |
Editorial Board YMJ-EditorialBoard-20131209.pdf
|